The progress of antitumor prodrug in target tumor therapy
Wang Chi
Abstract
Wang Chi
Abstract
Chemotherapy is one of the main tumor therapy in clinic,but the system toxicity of antitumor agent and its low concentration in the specific tumor position are still important disturbing factors in tumor treatment.Prodrug,which is from the modification of active drug constructure or pharmaceutical dosage form,greatly overcome the defect of chemotherapy agent and open a new way in target tumor treatment.At present,new advanced antitumor prodrugs contain directed-enzyme activated prodrug,carrier prodrug,lipophilic prodrug and so on.Several antitumor prodrugs have been reviewed.
A significance statement is not available in the OpenAlex record.
A contribution statement is not available in the OpenAlex record.
Method details are not available in the OpenAlex metadata.
Findings are not separately available in the OpenAlex metadata.
Limitations are not available in the OpenAlex metadata.
Application details are not available in the OpenAlex metadata.
Chemotherapy is one of the main tumor therapy in clinic,but the system toxicity of antitumor agent and its low concentration in the specific tumor position are still important disturbing factors in tumor treatment.Prodrug,which is from the modification of active drug constructure or pharmaceutical dosage form,greatly overcome the defect of chemotherapy agent and open a new way in target tumor treatment.At present,new advanced antitumor prodrugs contain directed-enzyme activated prodrug,carrier prodrug,lipophilic prodrug and so on.Several antitumor prodrugs have been reviewed.
Key concepts: Prodrug, Chemotherapy, Pharmacology, Drug, Adept, Medicine, Chemistry, Internal medicine